Drug company Merck applies for emergency use of antiviral pill

Edited by Ed Newman
2021-10-01 22:57:36

Pinterest
Telegram
Linkedin
WhatsApp

Drug company Merck applies for emergency use of antiviral pill

New York, October 1 (RHC)-- The United States reported more than 2,700 COVID-19 deaths on Thursday as the official U.S. pandemic death toll rapidly approached 700,000. 

On Friday, the drug company Merck announced it’s seeking emergency use of its antiviral drug molnupiravir from the FDA and other regulators around the world, after a late-stage clinical trial showed it reduced the risk of hospitalization or death in COVID-19 patients by about half. 

According to reports, if approved, the pill would be the first oral antiviral treatment for COVID-19.
 



Commentaries


MAKE A COMMENT
All fields required
NOT TO BE PUBLISHED
captcha challenge
up